Archive for December, 1969

Immunosuppressant Drug Prevents Tobacco Induced Lung Cancer in Mice - April 1, 2007

December 31st, 1969 at 07:00pm Under Heart Attack Symptoms


Rapamycin, an FDA-approved drug normally used to help prevent the body from rejecting organ and bone marrow transplants and also used to coat cardiac stents, was highly effective in preventing the development of tobacco-related lung tumors in mice. In a study published in the April 1, 2007 issue of Clinical Cancer Research, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, found that mice that were administered rapamycin one week after exposure to a very common tobacco-specific carcinogen showed a 90 percent decrease in the number of tumors, a 74 percent decrease in tumor size, and fewer abnormalities within their cancer cells.

By National Institutes of Health (NIH) News Releases Continue Reading Immunosuppressant Drug Prevents Tobacco Induced Lung Cancer in Mice - April 1, 2007

Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer - April 1, 2007

December 31st, 1969 at 07:00pm Under Heart Attack Symptoms

Researchers report that a variation in a portion of DNA strongly predicts prostate cancer risk and that this common variation may be responsible for up to 20 percent of prostate cancer cases in white men in the United States. The research was conducted by investigators from the National Cancer Institute (NCI), part of the National Institutes of Health, and their partners in the Cancer Genetic Markers of Susceptibility (CGEMS) initiative.

By National Institutes of Health (NIH) News Releases Continue Reading Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer - April 1, 2007

NIDA Survey Shows Lack of Substance Abuse Treatment Options for Offenders - April 2, 2007

December 31st, 1969 at 07:00pm Under Heart Attack Symptoms

Substance abuse treatment services for offenders are not widely available in all phases of the correctional system, according to the first set of findings from a national survey funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH).

By National Institutes of Health (NIH) News Releases Continue Reading NIDA Survey Shows Lack of Substance Abuse Treatment Options for Offenders - April 2, 2007

NIDA Study Identifies Genes That Might Help Some People Abstain From Smoking - April 2, 2007

December 31st, 1969 at 07:00pm Under Heart Attack Symptoms

Scientists supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, have for the first time identified genes that might increase a person’s ability to abstain from smoking. The breakthrough research was conducted by Dr. George Uhl at NIDA’s Intramural Research Program and a team led by Dr. Jed Rose at the Center for Nicotine and Smoking Cessation Research at Duke University Medical Center.

By National Institutes of Health (NIH) News Releases Continue Reading NIDA Study Identifies Genes That Might Help Some People Abstain From Smoking - April 2, 2007

NIAID Expands Capability for Influenza Research and Surveillance - April 2, 2007

December 31st, 1969 at 07:00pm Under Heart Attack Symptoms

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), today announced it is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance.

By National Institutes of Health (NIH) News Releases Continue Reading NIAID Expands Capability for Influenza Research and Surveillance - April 2, 2007

Intensive Psychotherapy More Effective Than Brief Therapy for Treating Bipolar Depression - April 2, 2007

December 31st, 1969 at 07:00pm Under Heart Attack Symptoms

Patients taking medications to treat bipolar disorder (http://www.nimh.nih.gov/healthinformation/bipolarmenu.cfm) are more likely to get well faster and stay well if they receive intensive psychotherapy, according to results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), funded by the National Institutes of Health’s (NIH) National Institute of Mental Health (NIMH).

By National Institutes of Health (NIH) News Releases Continue Reading Intensive Psychotherapy More Effective Than Brief Therapy for Treating Bipolar Depression - April 2, 2007

Assisted Reproductive Technologies Don’t Affect Genetic Code

December 31st, 1969 at 07:00pm Under Heart Attack Symptoms

Worries about the potential health risks of assisted reproduction technologies may be partly eased by a new study in mice that found the technologies had no detectable effects on the genetic code.

By NIH Research Matters from the National Institutes of Health (NIH) Continue Reading Assisted Reproductive Technologies Don’t Affect Genetic Code

Genetically Altered Mice See a More Colorful World

December 31st, 1969 at 07:00pm Under Heart Attack Symptoms

By giving mice the gene that allows people to see red hues, scientists have created rodents that can see a wider range of colors.

By NIH Research Matters from the National Institutes of Health (NIH) Continue Reading Genetically Altered Mice See a More Colorful World

New Insight into Mechanism of Aging

December 31st, 1969 at 07:00pm Under Heart Attack Symptoms

Researchers believe they've discovered how a rare genetic defect causes premature aging. The process they uncovered may also play a role in the normal aging process.

By NIH Research Matters from the National Institutes of Health (NIH) Continue Reading New Insight into Mechanism of Aging

Study Sheds Light on Medication Treatment Options for Bipolar Disorder - March 28, 2007

December 31st, 1969 at 07:00pm Under Heart Attack Symptoms

For depressed people with bipolar disorder who are taking a mood stabilizer, adding an antidepressant medication is no more effective than a placebo (sugar pill), according to results published online on March 28, 2007 in the New England Journal of Medicine. The results are part of the large-scale, multi-site Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), a $26.8 million clinical trial funded by the National Institutes of Health’s National Institute of Mental Health (NIMH).

By National Institutes of Health (NIH) News Releases Continue Reading Study Sheds Light on Medication Treatment Options for Bipolar Disorder - March 28, 2007

Previous Posts


Heart Attack Posts

Categories

Posts by Month